topSkip to main content

Menu, Secondary

Menu Trigger


Emory University

Emory University has developed a sensitive and specific diagnostic antibody blood test that will help determine antibody responses in people who have been infected by COVID-19.
Human clinical trials may begin on an antiviral compound which was discovered and developed by Emory University and shows promise as a potential treatment for COVID-19.
Emory doctors have helped create a new online tool allowing people everywhere to assess how likely it is that they have contracted the novel coronavirus.
Emory University will take part in an NIH-sponsored global clinical trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adult patients diagnosed with COVID-19.
An Emory University study shows that males gain a slight advantage in mental-rotation performance during the first years of formal schooling, and this advantage slowly grows with age, tripling in size by the end of adolescence.
A nationwide consortium of researchers has identified the first genetic defect linked to biliary atresia, a mysterious liver disease that is the leading cause for liver transplantation in children.
A new screening method using sensor particles and a urine test could catch organ transplant rejection much earlier, more comprehensively, and without a biopsy needle.
Exercise remains the most common practice among nationally tracked persons who are able to maintain weight loss over time.
Emory interventional radiologist David Prologo has developed a procedure that freezes a specific spot on the vagus nerve as a weight loss solution.
A randomized clinical study of adolescent boys with nonalcoholic fatty liver disease (NAFLD)  found that a diet low in free sugars (those sugars added to foods and beverages and occurring naturally in fruit juices) resulted in significant improvement in NAFLD compared to a usual diet.